Similar articles

• Inactivation of fusidic acid by resistant Streptomyces strains.

  von der Haar B, Rosenberg D, Dittrich W, Schrempf H. von der Haar B, et al. J Antibiot (Tokyo). 1991 Jul;44(7):785-92. doi: 10.7164/antibiotics.44.785. J Antibiot (Tokyo). 1991. PMID: 1880068
• Glycosylative inactivation of chalcomycin and tylosin by a clinically isolated Nocardia asteroides strain.

  Morisaki N, Hashimoto Y, Furihata K, Yazawa K, Tamura M, Mikami Y. Morisaki N, et al. J Antibiot (Tokyo). 2001 Feb;54(2):157-65. doi: 10.7164/antibiotics.54.157. J Antibiot (Tokyo). 2001. PMID: 11302489
• Microbial conversion of antibiotics. IV. Reduction of maridomycin.

  Nakahama K, Igarasi S. Nakahama K, et al. J Antibiot (Tokyo). 1974 Aug;27(8):605-9. doi: 10.7164/antibiotics.27.605. J Antibiot (Tokyo). 1974. PMID: 4436146 No abstract available.
• Fusidic acid: new opportunities with an old antibiotic.

  Anderson JD. Anderson JD. Can Med Assoc J. 1980 Apr 5;122(7):765-9. Can Med Assoc J. 1980. PMID: 6988070 Free PMC article. Review.
• [Antibiotic and blood protein binding and its therapeutic importance].

  Chojnowski W, Gralewicz J. Chojnowski W, et al. Pol Tyg Lek. 1974 May 27;29(21):905-7. Pol Tyg Lek. 1974. PMID: 4600556 Review. Polish. No abstract available.